×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KZR – kezar life sciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KZR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
02:47 pm
kzr
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?
Low
Report
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?
4/7
07:26 am
kzr
Shareholder Alert: Ademi LLP investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
Low
Report
Shareholder Alert: Ademi LLP investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
3/31
11:17 am
kzr
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders?
Low
Report
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders?
3/30
01:35 pm
kzr
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)
3/30
12:25 pm
kzr
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
Low
Report
Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders
3/30
08:29 am
kzr
KZR Stock Alert: Halper Sadeh LLC is Investigating Whether Kezar Life Sciences, Inc. is Obtaining a Fair Price for its Shareholders
High
Report
KZR Stock Alert: Halper Sadeh LLC is Investigating Whether Kezar Life Sciences, Inc. is Obtaining a Fair Price for its Shareholders
3/12
09:00 am
kzr
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Low
Report
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
1/9
06:01 am
kzr
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Medium
Report
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/6
09:29 pm
kzr
Form SCHEDULE 13G Kezar Life Sciences, Filed by: Baselake Partners, LP
Low
Report
Form SCHEDULE 13G Kezar Life Sciences, Filed by: Baselake Partners, LP
4/3
04:59 pm
kzr
Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc.
Low
Report
Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc.
4/3
04:49 pm
kzr
Form 8-K Kezar Life Sciences, For: Apr 01
Low
Report
Form 8-K Kezar Life Sciences, For: Apr 01
4/1
04:15 pm
kzr
Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC
Neutral
Report
Form SCHEDULE 13D/A Kezar Life Sciences, Filed by: TANG CAPITAL MANAGEMENT LLC
3/30
08:36 am
kzr
Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc.
Low
Report
Form SC14D9C Kezar Life Sciences, Filed by: Kezar Life Sciences, Inc.
3/30
08:33 am
kzr
Form 8-K Kezar Life Sciences, For: Mar 30
High
Report
Form 8-K Kezar Life Sciences, For: Mar 30
3/27
04:15 pm
kzr
Form 10-K Kezar Life Sciences, For: Dec 31
High
Report
Form 10-K Kezar Life Sciences, For: Dec 31
3/12
09:12 am
kzr
Form 8-K Kezar Life Sciences, For: Mar 06
Low
Report
Form 8-K Kezar Life Sciences, For: Mar 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/5
Form 4 Kezar Life Sciences, For: Feb 04 Filed by: Economides Vassiliki
28.2%
1/30 Form 8-K Kezar Life Sciences, For: Jan 30 26.9%
2/10 Form SC 13G/A Kezar Life Sciences, Filed by: AMGEN INC 24.0%
4/9 Kezar Provides Statement Regarding COVID-19 Pandemic 9.7%
12/19 Form 3 Kezar Life Sciences, For: Dec 18 Filed by: Garner Elizabeth 8.4%
6/27 Form 4 Kezar Life Sciences, For: Jun 25 Filed by: BERGER FRANKLIN M 7.5%
10/1 Kezar Life Sciences Announces Presentations of Four Abstracts at the 2019 ACR/ARP Annual Meeting 6.8%
12/19 Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors 6.3%
8/12 Form 4 Kezar Life Sciences, For: Aug 09 Filed by: Fowler John Franklin 6.2%
12/20 Form 4 Kezar Life Sciences, For: Dec 19 Filed by: Fowler John Franklin 5.7%
1/30 Form 8-K Kezar Life Sciences, For: Jan 30 26.9%
2/10 Form SC 13G/A Kezar Life Sciences, Filed by: AMGEN INC 24.0%
4/9 Kezar Provides Statement Regarding COVID-19 Pandemic 9.7%
12/19 Form 3 Kezar Life Sciences, For: Dec 18 Filed by: Garner Elizabeth 8.4%
6/27 Form 4 Kezar Life Sciences, For: Jun 25 Filed by: BERGER FRANKLIN M 7.5%
10/1 Kezar Life Sciences Announces Presentations of Four Abstracts at the 2019 ACR/ARP Annual Meeting 6.8%
12/19 Kezar Life Sciences Enhances Clinical Expertise with the Appointment of Elizabeth Garner, MD, MPH to its Board of Directors 6.3%
8/12 Form 4 Kezar Life Sciences, For: Aug 09 Filed by: Fowler John Franklin 6.2%
12/20 Form 4 Kezar Life Sciences, For: Dec 19 Filed by: Fowler John Franklin 5.7%
TOP News Decliners
5/28
Kezar Life Sciences Announces Acceptance of Abstract for Presentation of First in Patient Study with KZR-616 at EULAR 2019 Annual Meeting
-34.0%
2/26 Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference -14.2%
2/7 Form SC 13G/A Kezar Life Sciences, Filed by: FMR LLC -12.9%
6/13 Form 8-K Kezar Life Sciences, For: Jun 13 -12.5%
11/12 Kezar Announces Promising New Data with KZR-616 at the American College of Rheumatology Annual Meeting -11.2%
3/10 Form SC 13G/A Kezar Life Sciences, Filed by: FMR LLC -11.0%
10/1 Kezar Life Sciences Inc (NASDAQ: KZR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.50 price target on the stock. -10.1%
3/14 Kezar Life Sciences Inc (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at William Blair. -7.7%
3/13 Kezar Life Sciences Inc (NASDAQ: KZR) had its price target lowered by analysts at Wells Fargo & Co from $30.00 to $18.00. They now have an "overweight" rating on the stock. -7.4%
6/25 Form 8-K Kezar Life Sciences, For: Jun 25 -7.1%
2/26 Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference -14.2%
2/7 Form SC 13G/A Kezar Life Sciences, Filed by: FMR LLC -12.9%
6/13 Form 8-K Kezar Life Sciences, For: Jun 13 -12.5%
11/12 Kezar Announces Promising New Data with KZR-616 at the American College of Rheumatology Annual Meeting -11.2%
3/10 Form SC 13G/A Kezar Life Sciences, Filed by: FMR LLC -11.0%
10/1 Kezar Life Sciences Inc (NASDAQ: KZR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.50 price target on the stock. -10.1%
3/14 Kezar Life Sciences Inc (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at William Blair. -7.7%
3/13 Kezar Life Sciences Inc (NASDAQ: KZR) had its price target lowered by analysts at Wells Fargo & Co from $30.00 to $18.00. They now have an "overweight" rating on the stock. -7.4%
6/25 Form 8-K Kezar Life Sciences, For: Jun 25 -7.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: